Merck & Co. Retained Earnings decreased by 8.7% to $66.72B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.9%, from $66.10B to $66.72B. Over 5 years (FY 2020 to FY 2025), Retained Earnings shows an upward trend with a 9.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Consistent growth indicates strong profitability and effective reinvestment of earnings.
Retained earnings represent the cumulative net income of the company that has been reinvested in the business rather tha...
A core metric for mature, profitable companies across all sectors.
retained_earnings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $48.78B | $51.69B | $53.70B | $56.25B | $58.44B | $59.93B | $61.08B | $62.04B | $54.20B | $57.08B | $53.90B | $56.70B | $60.19B | $61.38B | $63.07B | $66.10B | $68.48B | $72.23B | $73.08B | $66.72B |
| QoQ Change | — | +6.0% | +3.9% | +4.8% | +3.9% | +2.6% | +1.9% | +1.6% | -12.6% | +5.3% | -5.6% | +5.2% | +6.2% | +2.0% | +2.7% | +4.8% | +3.6% | +5.5% | +1.2% | -8.7% |
| YoY Change | — | — | — | — | +19.8% | +15.9% | +13.8% | +10.3% | -7.3% | -4.7% | -11.8% | -8.6% | +11.1% | +7.5% | +17.0% | +16.6% | +13.8% | +17.7% | +15.9% | +0.9% |